173 related articles for article (PubMed ID: 9927747)
1. Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1.
Bai Y; Lee D; Yu T; Chasin LA
Nucleic Acids Res; 1999 Feb; 27(4):1126-34. PubMed ID: 9927747
[TBL] [Abstract][Full Text] [Related]
2. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
Mayeda A; Helfman DM; Krainer AR
Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
[TBL] [Abstract][Full Text] [Related]
3. Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.
Eperon IC; Makarova OV; Mayeda A; Munroe SH; Cáceres JF; Hayward DG; Krainer AR
Mol Cell Biol; 2000 Nov; 20(22):8303-18. PubMed ID: 11046128
[TBL] [Abstract][Full Text] [Related]
4. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
5. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
[TBL] [Abstract][Full Text] [Related]
6. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.
Sun Q; Mayeda A; Hampson RK; Krainer AR; Rottman FM
Genes Dev; 1993 Dec; 7(12B):2598-608. PubMed ID: 8276242
[TBL] [Abstract][Full Text] [Related]
7. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
[TBL] [Abstract][Full Text] [Related]
8. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
[TBL] [Abstract][Full Text] [Related]
9. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.
Rooke N; Markovtsov V; Cagavi E; Black DL
Mol Cell Biol; 2003 Mar; 23(6):1874-84. PubMed ID: 12612063
[TBL] [Abstract][Full Text] [Related]
10. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
[TBL] [Abstract][Full Text] [Related]
11. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
Cáceres JF; Stamm S; Helfman DM; Krainer AR
Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
[TBL] [Abstract][Full Text] [Related]
12. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
[TBL] [Abstract][Full Text] [Related]
14. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
Liu X; Mayeda A; Tao M; Zheng ZM
J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
[TBL] [Abstract][Full Text] [Related]
15. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5' and 3' splice site selection.
Fu XD; Mayeda A; Maniatis T; Krainer AR
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11224-8. PubMed ID: 1454802
[TBL] [Abstract][Full Text] [Related]
16. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.
Mayeda A; Krainer AR
Cell; 1992 Jan; 68(2):365-75. PubMed ID: 1531115
[TBL] [Abstract][Full Text] [Related]
17. SRp30c is a repressor of 3' splice site utilization.
Simard MJ; Chabot B
Mol Cell Biol; 2002 Jun; 22(12):4001-10. PubMed ID: 12024014
[TBL] [Abstract][Full Text] [Related]
18. Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo.
Pollard AJ; Sparey C; Robson SC; Krainer AR; Europe-Finner GN
J Clin Endocrinol Metab; 2000 May; 85(5):1928-36. PubMed ID: 10843177
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
Blanco FJ; Bernabeu C
Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
[TBL] [Abstract][Full Text] [Related]
20. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
D'Souza I; Schellenberg GD
J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
